IM Cannabis Corp. Files October 2024 6-K Report
Ticker: IMCC · Form: 6-K · Filed: 2024-10-04T00:00:00.000Z
Sentiment: neutral
Topics: regulatory-filing, foreign-private-issuer, 6-K
TL;DR
IM Cannabis Corp. filed its October 6-K, confirming its status as a foreign private issuer based in Israel.
AI Summary
IM Cannabis Corp. filed a Form 6-K on October 4, 2024, reporting for the month of October 2024. The company, incorporated in Israel with its principal executive offices at Kibbutz Glil Yam, Central District, Israel, is a foreign private issuer. IM Cannabis Corp. is listed under the SIC code 2833 for Medicinal Chemicals & Botanical Products and has its main business address in Toronto, Canada.
Why It Matters
This filing provides an update on IM Cannabis Corp.'s reporting status as a foreign private issuer, which is relevant for investors tracking regulatory compliance and disclosures.
Risk Assessment
Risk Level: low — This filing is a routine report of foreign private issuer status and does not contain significant new financial or operational information that would immediately impact risk.
Key Players & Entities
- IM Cannabis Corp. (company) — Registrant
- October 4, 2024 (date) — Filing Date
- 2833 (other) — Standard Industrial Classification Code
- Kibbutz Glil Yam, Central District, Israel (location) — Principal Executive Offices
- Toronto, Canada (location) — Business Address
FAQ
What is the primary purpose of this Form 6-K filing for IM Cannabis Corp.?
The Form 6-K is a Report of Foreign Private Issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, for the month of October 2024.
Where are IM Cannabis Corp.'s principal executive offices located?
IM Cannabis Corp.'s principal executive offices are located at Kibbutz Glil Yam, Central District, Israel, 4690500.
What is IM Cannabis Corp.'s Standard Industrial Classification (SIC) code?
IM Cannabis Corp.'s SIC code is 2833, which corresponds to Medicinal Chemicals & Botanical Products.
Does IM Cannabis Corp. file annual reports under Form 20-F or Form 40-F?
The filing indicates that IM Cannabis Corp. files annual reports under Form 20-F.
What is the Commission File Number for IM Cannabis Corp.?
The Commission File Number for IM Cannabis Corp. is 001-40065.
Filing Stats: 342 words · 1 min read · ~1 pages · Grade level 16.1 · Accepted 2024-10-04 07:14:17
Filing Documents
- zk2432108.htm (6-K) — 10KB
- exhibit_99-1.htm (EX-99.1) — 23KB
- 0001178913-24-003212.txt ( ) — 34KB
From the Filing
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of October 2024 . Commission File Number: 001-40065 IM Cannabis Corp. (Exact Name of Registrant as Specified in Charter) Kibbutz Glil Yam, Central District, Israel 4690500 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F. Form 20-F Form 40-F Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ____ Note : Regulation S-T Rule 101(b)(1) only permits the submission in paper of a Form 6-K if submitted solely to provide an attached annual report to security holders. Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ____ Note : Regulation S-T Rule 101(b)(7) only permits the submission in paper of a Form 6-K if submitted to furnish a report or other document that the registrant foreign private issuer must furnish and make public under the laws of the jurisdiction in which the registrant is incorporated, domiciled or legally organized (the registrant's "home country"), or under the rules of the home country exchange on which the registrant's securities are traded, as long as the report or other document is not a press release, is not required to be and has not been distributed to the registrant's security holders, and, if discussing a material event, has already been the subject of a Form 6-K submission or other Commission filing on EDGAR. SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. IM CANNABIS CORP. (Registrant) Date: October 4, 2024 By: /s/ Oren Shuster Name: Oren Shuster Title: Chief Executive Officer and Director EXHIBIT INDEX 99.1 News Release dated October 4, 2024